Skip to main content

Table 2 Distribution of monocyte subsets of PCM-p during the follow-up

From: Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment

ID patient Before Treatment During the treatment
CD45+CD14+ CD14+CD16- CD14+CD16+ CD14 + CD16++ CD45+CD14+ CD14+CD16- CD14+CD16+ CD14+CD16++ Length of treatment (months)
P3 348 327 16 5 331 307 6 18 17 (ITC)
P6 933 716 158 58 221 430 16 18 20 (CMX)
P7 1164 959 118 88 776 610 4 23 20 (ITC)
P8 457 346 82 30 214 290 6 10 20 (CMX)
P9 511 350 141 20 273 360 2 15 17 (ITC)
Mean ± SEM 682.6 ± 156.0 A 539.6 ± 127.6 103.0 ± 25.2 A 40.2 ± 14.7 363.0 ± 105.4 B 399.4 ± 58.0 6.8 ± 2.4 B 16.8 ± 2.1 18.8 ± 1.4
  1. Different letters indicate significant differences between the groups (p ≤0.05, t-paired test; A >B).
  2. Values expressed as cell counts/μl.